Dyadic International DYAI
NASDAQ DYAI
$0.69 -0.01 (-1.43%)
At close: Aug 21, 2026 · 4:00 PM EDT

Dyadic International (DYAI) Amortizatization of Intangibles (2018 - 2022)

Dyadic International (DYAI) posted Amortizatization of Intangibles of -$3304.0 for Q4 2022, down 127.82% sequentially from $11877.0 in Q3 2022, and down 104.38% YoY from $75419.0 in Q4 2021.

Dyadic International (DYAI) Amortizatization of Intangibles (2018 - 2022) Analysis & Trends

Dyadic International has reported Amortizatization of Intangibles for 5 years, with the latest figure at -$3304.0 in Q4 2022.

  • Quarterly Amortizatization of Intangibles fell 104.38% year-over-year to -$3304.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $33790.0 (down 89.75% YoY) and the FY2022 annual result came in at $33790.0, down 89.75% from the prior year.
  • Amortizatization of Intangibles declined to -$3304.0 in Q4 2022 per DYAI's latest filing, from $11877.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $64.0 million in Q1 2021 and troughed at -$63.8 million in Q2 2021.
  • A 5-year average of $78476.6 and a median of $67001.5 in 2019 frame the typical range for Amortizatization of Intangibles.
  • The widest YoY moves for Amortizatization of Intangibles: up 59524.64% in 2021, down 52105.51% in 2021.
  • Over 5 years, Amortizatization of Intangibles stood at $78180.0 in 2018, then retreated by 27.29% to $56846.0 in 2019, then declined by 13.53% to $49154.0 in 2020, then soared by 53.43% to $75419.0 in 2021, then sank by 104.38% to -$3304.0 in 2022.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered -$3304.0, $11877.0, and -$13.4 million for Q4 2022, Q3 2022, and Q2 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Dyadic International 19.98 Mn 19.98 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 -3,304.00
Dec 31, 2022 -3,304.00
Sep 30, 2022 11,877.00
Sep 30, 2022 11,877.00
Jun 30, 2022 -13.42 Mn
Jun 30, 2022 -13.42 Mn
Mar 31, 2022 13.45 Mn
Mar 31, 2022 13.45 Mn
Dec 31, 2021 75,419.00
Dec 31, 2021 75,419.00
Sep 30, 2021 94,712.00
Sep 30, 2021 94,712.00
Jun 30, 2021 -63.79 Mn
Jun 30, 2021 -63.79 Mn
Mar 31, 2021 63.95 Mn
Mar 31, 2021 63.95 Mn
Dec 31, 2020 49,154.00
Dec 31, 2020 49,154.00
Sep 30, 2020 52,204.00
Sep 30, 2020 52,204.00